Characterization of a human cytomegalovirus with phosphorylation site mutations in the immediate-early 2 protein

Julie A Heider1, Yongjun Yu, Thomas Shenk

  • 1Department of Molecular Biology, Princeton University, Princeton, New Jersey 08544-1014, USA.

Journal of Virology
|December 26, 2001
PubMed

Insights

A novel human cytomegalovirus mutant with altered IE2 protein phosphorylation showed no growth defects but enhanced transactivation of the simian virus 40 early promoter in human cells.

Area of Science:

  • Virology
  • Molecular Biology
  • Cellular Biology

Background:

  • Human cytomegalovirus (HCMV) immediate-early 2 (IE2) protein plays a crucial role in viral gene regulation.
  • Phosphorylation of IE2 protein residues is known to influence its function.
  • Understanding IE2 protein modifications is key to deciphering HCMV replication and pathogenesis.

Purpose of the Study:

  • To investigate the functional impact of specific IE2 protein phosphorylation sites on HCMV replication and promoter transactivation.
  • To characterize a novel HCMV mutant (TNsubIE2P) with alanine substitutions at four key phosphorylation sites in the IE2 protein.
  • To assess the effect of these modifications on viral growth, viral promoter activation, and heterologous promoter transactivation.

Main Methods:

  • Construction of a recombinant HCMV mutant (TNsubIE2P) by site-directed mutagenesis, replacing four phosphorylated residues in the IE2 protein with alanine.
  • Assessment of viral growth kinetics at various multiplicities of infection (MOI).
  • Analysis of viral promoter activation (major immediate-early, UL4, UL44) and transactivation of an endogenous simian virus 40 early promoter in infected human fibroblasts.
  • Examination of IE2 protein modification, specifically sumoylation.

Main Results:

  • The TNsubIE2P mutant exhibited growth kinetics comparable to wild-type HCMV at both low and high MOI.
  • Mutant virus demonstrated similar activation levels and kinetics for HCMV major immediate-early, UL4, and UL44 promoters compared to wild-type.
  • The TNsubIE2P mutant showed accelerated and enhanced transactivation of the simian virus 40 early promoter in infected human fibroblasts.
  • The study also explored the sumoylated state of the modified IE2 protein.

Conclusions:

  • Specific phosphorylation sites in the HCMV IE2 protein are not essential for viral replication or the activation of viral promoters.
  • Modification of these phosphorylation sites can enhance the IE2 protein's ability to transactivate heterologous promoters, suggesting a regulatory role in viral gene expression.
  • These findings provide insights into the complex post-translational modifications of the IE2 protein and their impact on HCMV transcriptional regulation.

Related Concept Videos

Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Leaky Scanning02:28

Leaky Scanning

During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA.  Marilyn Kozak discovered that the sequence RCCAUGG (where R stands for...
Viral Mutations00:36

Viral Mutations

A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material for adaptive...